Heterocyclic CGRP antagonists for the treatment of migraine

Details for Australian Patent Application No. 2005228881 (hide)

Owner Bristol-Myers Squibb Company

Inventors Han, Xiaojun; Degnan, Andrew P.; Dubowchik, Gene M.; Macor, John E.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005228881

PCT Pub. Number WO2005/095383

Priority 60/557,408 29.03.04 US

Filing date 28 March 2005

Wipo publication date 13 October 2005

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/095383 Priority application(s): WO2005/095383

9 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005228886-Geldanamycin and derivatives inhibit cancer invasion and identify novel targets

2005228875-Liquid level maintaining device